AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
30.93
-0.33 (-1.06%)
Mar 2, 2026, 4:00 PM EST - Market closed
AtriCure Revenue
In the year 2025, AtriCure had annual revenue of $534.53M with 14.88% growth. AtriCure had revenue of $140.50M in the quarter ending December 31, 2025, with 13.05% growth.
Revenue (ttm)
$534.53M
Revenue Growth
+14.88%
P/S Ratio
2.88
Revenue / Employee
$395,947
Employees
1,350
Market Cap
1.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 534.53M | 69.22M | 14.88% |
| Dec 31, 2024 | 465.31M | 66.06M | 16.55% |
| Dec 31, 2023 | 399.25M | 68.87M | 20.84% |
| Dec 31, 2022 | 330.38M | 56.05M | 20.43% |
| Dec 31, 2021 | 274.33M | 67.80M | 32.83% |
| Dec 31, 2020 | 206.53M | -24.28M | -10.52% |
| Dec 31, 2019 | 230.81M | 29.18M | 14.47% |
| Dec 31, 2018 | 201.63M | 26.91M | 15.40% |
| Dec 31, 2017 | 174.72M | 19.61M | 12.64% |
| Dec 31, 2016 | 155.11M | 25.35M | 19.54% |
| Dec 31, 2015 | 129.76M | 22.30M | 20.75% |
| Dec 31, 2014 | 107.45M | 25.57M | 31.22% |
| Dec 31, 2013 | 81.89M | 11.64M | 16.57% |
| Dec 31, 2012 | 70.25M | 5.85M | 9.08% |
| Dec 31, 2011 | 64.40M | 5.40M | 9.14% |
| Dec 31, 2010 | 59.01M | 4.47M | 8.20% |
| Dec 31, 2009 | 54.53M | -723.47K | -1.31% |
| Dec 31, 2008 | 55.26M | 6.95M | 14.38% |
| Dec 31, 2007 | 48.31M | 10.07M | 26.32% |
| Dec 31, 2006 | 38.24M | 7.29M | 23.54% |
| Dec 31, 2005 | 30.96M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.68B |
| ICU Medical | 2.23B |
| Warby Parker | 871.91M |
| Azenta | 595.03M |
| LeMaitre Vascular | 249.60M |
| STAAR Surgical Company | 230.59M |
| BioLife Solutions | 96.21M |
| Kestra Medical Technologies | 74.26M |
ATRC News
- 7 days ago - AtriCure to Participate in the Citizens Life Sciences Conference - Business Wire
- 13 days ago - AtriCure, Inc. (ATRC) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results - Business Wire
- 5 weeks ago - AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 6 weeks ago - AtriCure, Inc. (ATRC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026 - Business Wire
- 2 months ago - AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference - Business Wire
- 2 months ago - AtriCure Announces the First Patients Treated with Novel Dual Energy Platform - Business Wire